MFDS
- Marketing authorisation holder: GLAXOSMITHKLINE LLC
- Status: likely_approved
🇰🇷 Exdensur in South Korea
Exdensur (DEPEMOKIMAB) regulatory status in South Korea.
Marketing authorisation
Exdensur in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in South Korea
Frequently asked questions
Is Exdensur approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Exdensur in South Korea?
GLAXOSMITHKLINE LLC holds the South Korean marketing authorisation.